MAXONA Pharmaceuticals
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Village Dr Apt 719, King Of Prussia,...Phone Number
(484) 684-7737Website
www.maxonapharm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About MAXONA Pharmaceuticals
MAXONA Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative, non-addictive pain therapies for acute and chronic pain. Their lead compound, MAX-001, is a non-NSAID, non-opioid painkiller with a proven safety profile and effectiveness comparable to opioids, without the associated risks. The company aims to address the needs of over 255 million Americans suffering from pain, leveraging their expertise in drug development and clinical trials. MAXONA is committed to creating patient-centric therapies that are safe, effective, and clinically validated.Explore more
MAXONA Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MAXONA Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at MAXONA Pharmaceuticals
Website visits: Recent activity has been detected on your website
MAXONA Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if MAXONA Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MAXONA Pharmaceuticals has new funding data
Product Launch: Get notified when MAXONA Pharmaceuticals launches new products
Earning: See what the market has to say on MAXONA Pharmaceuticals recently announced quarterly report
Check out if MAXONA Pharmaceuticals is spiking on competitors!
Click to see if MAXONA Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to MAXONA Pharmaceuticals
Compare insights from companies similar to MAXONA Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MAXONA Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MAXONA Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MAXONA Pharmaceuticals.
MAXONA Pharmaceuticals financials insights
Gather financial insights about MAXONA Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$5.6M
MAXONA Pharmaceuticals Tech Stack
A closer look at the technologies used by MAXONA Pharmaceuticals
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Left Company
Executive Move
MAXONA Pharmaceuticals News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MAXONA Pharmaceuticals
Sign Up For FreeTo access detailed company insights
MAXONA Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative, non-addictive pain therapies for acute and chronic pain. Their lead compound, MAX-001, is a non-NSAID, non-opioid painkiller with a proven safety profile and effectiveness comparable to opioids, without the associated risks. The company aims to addre... Read More
